Skip to content

Study and Application of minimally invasive interventional therapy for thyroid tumor combined with Traditional Chinese medicine

Study and Application of minimally invasive interventional therapy for thyroid tumor combined with Traditional Chinese medicine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037710
Enrollment
Unknown
Registered
2020-08-30
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid tumor

Interventions

Sponsors

Shanghai Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 78 Years

Inclusion criteria

Inclusion criteria: (1) It conforms to the western medicine diagnostic standard of thyroid tumor and the Traditional Chinese medicine diagnostic standard of gall disease. (2) Aged from 18 to 78 (including 18 and 78). (3) Benign thyroid nodules or thyroid micropapillary carcinomas may be diagnosed by imaging or needle aspiration cytology or coarse needle aspiration biopsy, and ultrasound may indicate calcification and/or abundant blood flow signals in the nodules. (4) The external convex of the tubercle affects the aesthetic appearance or has a higher requirement for postoperative aesthetic appearance. (5) Those who refuse surgical resection and require minimally invasive surgery. (6) Patients requiring minimally invasive surgery due to excessive anxiety about thyroid tumors.

Exclusion criteria

Exclusion criteria: (1) Severe damage to vital organs, mental illness, obvious abnormalities in coagulation and thyroid function. (2) Pregnant. (3) According to the judgment of the researchers, other medical histories that reduce the possibility of enrollment or complicate enrollment, such as frequent changes in the work environment, may easily lead to loss of follow-up. (4) Subjects who are participating in clinical studies of other drugs or have just finished clinical trials of other drugs for less than 3 months.

Design outcomes

Primary

MeasureTime frame
Changes of thyroid tumors;Thyroid function;

Secondary

MeasureTime frame
TCM syndrome integral;

Countries

China

Contacts

Public ContactWang Xiaoping

Traditional Chinese Medicine Hospital of Shanghai

prowxp@163.com+86 18801876545

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026